Correlation Between Boston Scientific and CONMED

Can any of the company-specific risk be diversified away by investing in both Boston Scientific and CONMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Scientific and CONMED into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Boston Scientific Corp and CONMED, you can compare the effects of market volatilities on Boston Scientific and CONMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Scientific with a short position of CONMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Scientific and CONMED.

Diversification Opportunities for Boston Scientific and CONMED

0.56

Correlation Coefficient

Boston Scientific  CONMED

Very weak diversification

The 3 months correlation between Boston and CONMED is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Boston Scientific Corp and CONMED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CONMED and Boston Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Scientific Corp are associated (or correlated) with CONMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CONMED has no effect on the direction of Boston Scientific i.e., Boston Scientific and CONMED go up and down completely randomly.

Pair Corralation between Boston Scientific and CONMED

Considering the 90-day investment horizon Boston Scientific Corp is expected to generate 0.49 times more return on investment than CONMED. However, Boston Scientific Corp is 2.03 times less risky than CONMED. It trades about 0.12 of its potential returns per unit of risk. CONMED is currently generating about -0.02 per unit of risk. If you would invest  4,604  in Boston Scientific Corp on October 7, 2024 and sell it today you would earn a total of  4,465  from holding Boston Scientific Corp or generate 96.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Boston Scientific Corp  vs.  CONMED

Boston Scientific Corp

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in February 2025.

CONMED

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CONMED are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, CONMED may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Boston Scientific and CONMED

The main advantage of trading using opposite Boston Scientific and CONMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Scientific position performs unexpectedly, CONMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will offset losses from the drop in CONMED's long position.

The idea behind Boston Scientific Corp and CONMED pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.